Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
about
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Gemcitabine, Docetaxel, and Hy ...... ent or Refractory Osteosarcoma
@en
type
label
Gemcitabine, Docetaxel, and Hy ...... ent or Refractory Osteosarcoma
@en
prefLabel
Gemcitabine, Docetaxel, and Hy ...... ent or Refractory Osteosarcoma
@en
P4844
P1050
P1476
A Phase 1/2 Study of Gemcitabi ...... ts With Recurrent Osteosarcoma
@en
P3098
NCT03598595
P580
2019-01-28T00:00:00Z
P582
2020-03-02T00:00:00Z